MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma - Stroh, Jacob; Seckinger, Anja; Heider, Michael; Rudelius, Martina; Eichner, Ruth; Schick, Markus; Slawska, Jolanta; Emde-Rajaratnam, Martina; Salwender, Hans; Bertsch, Uta; Goldschmidt, Hartmut; Weisel, Katja; et al. (Blood advances, 2022)
Gesehen am 25.03.2022